Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

National Wilm's Tumor Study Late Effects
National Wilm's Tumor Study Late Effects
Status: Enrolling
Updated:  9/24/2009
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
National Wilm's Tumor Study Late Effects
National Wilm's Tumor Study Late Effects
Status: Enrolling
Updated: 9/24/2009
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate
A Phase II Feasibility Study of Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate Followed ny Adjuvant ALIMTA/Cisplatin
Status: Enrolling
Updated:  10/30/2009
Brigham and Women's Hosp
mi
from
Boston, MA
Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate
A Phase II Feasibility Study of Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate Followed ny Adjuvant ALIMTA/Cisplatin
Status: Enrolling
Updated: 10/30/2009
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate
A Phase II Feasibility Study of Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate Followed ny Adjuvant ALIMTA/Cisplatin
Status: Enrolling
Updated:  10/30/2009
Dana-Farber Cancer Institute
mi
from
Boston, MA
Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate
A Phase II Feasibility Study of Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate Followed ny Adjuvant ALIMTA/Cisplatin
Status: Enrolling
Updated: 10/30/2009
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
A Phase I/II Trial of Abraxane in Combination With Carboplatin, Erbitux and Intensity Modulated Radiation Therapy (IMRT)for Treatment of Locally Advanced Squamous Cancer of the Head and Neck
Status: Enrolling
Updated:  10/30/2009
Dana-Farber Cancer Institute
mi
from
Boston, MA
Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
A Phase I/II Trial of Abraxane in Combination With Carboplatin, Erbitux and Intensity Modulated Radiation Therapy (IMRT)for Treatment of Locally Advanced Squamous Cancer of the Head and Neck
Status: Enrolling
Updated: 10/30/2009
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma
A Phase I Trial of Extrapleural Pneumonectomy/Pleurectomy Decortication, Intrathoracic/Intraperitoneal Hyperthermic (IOHC) Cisplatin and Gemcitabine With Intravenous Amifostine and Sodium Thiosulfate Cytoprotection for Patients With Resectable Malignant Pleural Mesothelioma
Status: Enrolling
Updated:  10/30/2009
Brigham and Women's Hosp
mi
from
Boston, MA
Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma
A Phase I Trial of Extrapleural Pneumonectomy/Pleurectomy Decortication, Intrathoracic/Intraperitoneal Hyperthermic (IOHC) Cisplatin and Gemcitabine With Intravenous Amifostine and Sodium Thiosulfate Cytoprotection for Patients With Resectable Malignant Pleural Mesothelioma
Status: Enrolling
Updated: 10/30/2009
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
In Vivo Confocal Microscopy Tumor Atlas Study
In Vivo Confocal Microscopy Tumor Atlas Study
Status: Enrolling
Updated:  11/10/2009
Barrow Neurological Institute - St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
In Vivo Confocal Microscopy Tumor Atlas Study
In Vivo Confocal Microscopy Tumor Atlas Study
Status: Enrolling
Updated: 11/10/2009
Barrow Neurological Institute - St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Investigating the Improvement in 4D CT Images Using AV Biofeedback
Investigating the Improvement in 4D CT Images Using Audiovisual Biofeedback: An Intra-fraction and an Inter-fraction Evaluation.
Status: Enrolling
Updated:  11/16/2009
University of Maryland
mi
from
Baltimore, MD
Investigating the Improvement in 4D CT Images Using AV Biofeedback
Investigating the Improvement in 4D CT Images Using Audiovisual Biofeedback: An Intra-fraction and an Inter-fraction Evaluation.
Status: Enrolling
Updated: 11/16/2009
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Multi-Media Imagery Program for Breast Cancer Patients (Phase II)
Multi-Media Imagery Program for Breast Cancer Patients (Phase II)
Status: Enrolling
Updated:  12/16/2009
Gilda's Club Seattle
mi
from
Seattle, WA
Multi-Media Imagery Program for Breast Cancer Patients (Phase II)
Multi-Media Imagery Program for Breast Cancer Patients (Phase II)
Status: Enrolling
Updated: 12/16/2009
Gilda's Club Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials
Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors
Pilot Study Evaluating the Feasibility of Real-Time, Magnetic Resonance Thermal Imaging and Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors
Status: Enrolling
Updated:  12/30/2009
North Shore University Hospital
mi
from
Manhasset, NY
Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors
Pilot Study Evaluating the Feasibility of Real-Time, Magnetic Resonance Thermal Imaging and Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors
Status: Enrolling
Updated: 12/30/2009
North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
How Our Immune System Can Help Fight Cancer
The Effect of Genetic Polymorphisms in Indoleamine 2, 3-Dioxygenase in Epithelial Ovarian Cancer
Status: Enrolling
Updated:  1/5/2010
Winthrop University Hospital
mi
from
Mineola, NY
How Our Immune System Can Help Fight Cancer
The Effect of Genetic Polymorphisms in Indoleamine 2, 3-Dioxygenase in Epithelial Ovarian Cancer
Status: Enrolling
Updated: 1/5/2010
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma
Phase II Study of Adjuvant Gemcitabine Started One Week After Laparoscopic
Status: Enrolling
Updated:  1/7/2010
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma
Phase II Study of Adjuvant Gemcitabine Started One Week After Laparoscopic
Status: Enrolling
Updated: 1/7/2010
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)
TheraSphere HUD For Treatment of Unresectable HCC
Status: Enrolling
Updated:  1/12/2010
University of Louisville Hospital / Norton Hospital
mi
from
Louisville, KY
TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)
TheraSphere HUD For Treatment of Unresectable HCC
Status: Enrolling
Updated: 1/12/2010
University of Louisville Hospital / Norton Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Pilot Study Assessing Oxidative Stress in Children
Prevalence of Oxidative Stress in Critically Ill Children and Its Relationship to Adrenal Insufficiency; a Pilot Study
Status: Enrolling
Updated:  1/15/2010
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Pilot Study Assessing Oxidative Stress in Children
Prevalence of Oxidative Stress in Critically Ill Children and Its Relationship to Adrenal Insufficiency; a Pilot Study
Status: Enrolling
Updated: 1/15/2010
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Molecular Imaging of Breast Cancer With Breast PET/CT
Molecular Imaging of Breast Cancer With Breast PET/CT
Status: Enrolling
Updated:  1/19/2010
UC David Medical Center
mi
from
Sacramento, CA
Molecular Imaging of Breast Cancer With Breast PET/CT
Molecular Imaging of Breast Cancer With Breast PET/CT
Status: Enrolling
Updated: 1/19/2010
UC David Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy.
The Effects of Exercise Training on Tumor Vascularity and Response to Neoadjuvant Therapy in Operable Breast Cancer: A Phase I-II Study
Status: Enrolling
Updated:  2/11/2010
Duke Univ Med Ctr
mi
from
Durham, NC
Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy.
The Effects of Exercise Training on Tumor Vascularity and Response to Neoadjuvant Therapy in Operable Breast Cancer: A Phase I-II Study
Status: Enrolling
Updated: 2/11/2010
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
The Clinical and Biochemical Effect of Therapeutic Massage on Fatigue and Insomnia in Women With Breast Cancer Receiving Radiation Therapy
The Clinical and Biochemical Effect of Therapeutic Massage on Fatigue and Insomnia in Women With Breast Cancer Receiving Radiation Therapy
Status: Enrolling
Updated:  2/17/2010
FMHHS Cancer Care Center
mi
from
New Albany, IN
The Clinical and Biochemical Effect of Therapeutic Massage on Fatigue and Insomnia in Women With Breast Cancer Receiving Radiation Therapy
The Clinical and Biochemical Effect of Therapeutic Massage on Fatigue and Insomnia in Women With Breast Cancer Receiving Radiation Therapy
Status: Enrolling
Updated: 2/17/2010
FMHHS Cancer Care Center
mi
from
New Albany, IN
Click here to add this to my saved trials
A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis
A Phase 2, Open-label, Proof-of-concept Study to Assess the Ability to Detect Tumours and Angiogenesis Via the Expression of ανβ3/5 Integrin Receptors by [18F]AH-111585 PET Imaging
Status: Enrolling
Updated:  3/25/2010
GE Healthcare Office
mi
from
Princeton, NJ
A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis
A Phase 2, Open-label, Proof-of-concept Study to Assess the Ability to Detect Tumours and Angiogenesis Via the Expression of ανβ3/5 Integrin Receptors by [18F]AH-111585 PET Imaging
Status: Enrolling
Updated: 3/25/2010
GE Healthcare Office
mi
from
Princeton, NJ
Click here to add this to my saved trials
Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of 0.1% Uracil Ointment (1UO)in the Prevention of Hand-Foot Syndrome (HFS) in Patients With Metastatic Breast Cancer Treated With Capecitabine
Status: Enrolling
Updated:  4/8/2010
Bruno Cancer Center
mi
from
Birmingham, AL
Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of 0.1% Uracil Ointment (1UO)in the Prevention of Hand-Foot Syndrome (HFS) in Patients With Metastatic Breast Cancer Treated With Capecitabine
Status: Enrolling
Updated: 4/8/2010
Bruno Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of 0.1% Uracil Ointment (1UO)in the Prevention of Hand-Foot Syndrome (HFS) in Patients With Metastatic Breast Cancer Treated With Capecitabine
Status: Enrolling
Updated:  4/8/2010
Comprehensive Cancer Center
mi
from
Palm Springs, CA
Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of 0.1% Uracil Ointment (1UO)in the Prevention of Hand-Foot Syndrome (HFS) in Patients With Metastatic Breast Cancer Treated With Capecitabine
Status: Enrolling
Updated: 4/8/2010
Comprehensive Cancer Center
mi
from
Palm Springs, CA
Click here to add this to my saved trials
Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of 0.1% Uracil Ointment (1UO)in the Prevention of Hand-Foot Syndrome (HFS) in Patients With Metastatic Breast Cancer Treated With Capecitabine
Status: Enrolling
Updated:  4/8/2010
Research Institute of Deaconess Clinic
mi
from
Evansville, IN
Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of 0.1% Uracil Ointment (1UO)in the Prevention of Hand-Foot Syndrome (HFS) in Patients With Metastatic Breast Cancer Treated With Capecitabine
Status: Enrolling
Updated: 4/8/2010
Research Institute of Deaconess Clinic
mi
from
Evansville, IN
Click here to add this to my saved trials
Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of 0.1% Uracil Ointment (1UO)in the Prevention of Hand-Foot Syndrome (HFS) in Patients With Metastatic Breast Cancer Treated With Capecitabine
Status: Enrolling
Updated:  4/8/2010
Cancer Care Center
mi
from
New Albany, IN
Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of 0.1% Uracil Ointment (1UO)in the Prevention of Hand-Foot Syndrome (HFS) in Patients With Metastatic Breast Cancer Treated With Capecitabine
Status: Enrolling
Updated: 4/8/2010
Cancer Care Center
mi
from
New Albany, IN
Click here to add this to my saved trials
Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of 0.1% Uracil Ointment (1UO)in the Prevention of Hand-Foot Syndrome (HFS) in Patients With Metastatic Breast Cancer Treated With Capecitabine
Status: Enrolling
Updated:  4/8/2010
Kansas City Cancer Centers
mi
from
Overland Park, KA
Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of 0.1% Uracil Ointment (1UO)in the Prevention of Hand-Foot Syndrome (HFS) in Patients With Metastatic Breast Cancer Treated With Capecitabine
Status: Enrolling
Updated: 4/8/2010
Kansas City Cancer Centers
mi
from
Overland Park, KA
Click here to add this to my saved trials
Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of 0.1% Uracil Ointment (1UO)in the Prevention of Hand-Foot Syndrome (HFS) in Patients With Metastatic Breast Cancer Treated With Capecitabine
Status: Enrolling
Updated:  4/8/2010
Signal Point Clinical Research Center
mi
from
Middleton, OH
Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of 0.1% Uracil Ointment (1UO)in the Prevention of Hand-Foot Syndrome (HFS) in Patients With Metastatic Breast Cancer Treated With Capecitabine
Status: Enrolling
Updated: 4/8/2010
Signal Point Clinical Research Center
mi
from
Middleton, OH
Click here to add this to my saved trials
Women With Cancer: An Exercise Study to Promote Health
An Exercise Intervention to Improve Health in Postmenopausal Cancer Survivors
Status: Enrolling
Updated:  4/12/2010
Yale University
mi
from
New Haven, CT
Women With Cancer: An Exercise Study to Promote Health
An Exercise Intervention to Improve Health in Postmenopausal Cancer Survivors
Status: Enrolling
Updated: 4/12/2010
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Bevacizumab and Radiation Therapy for Sarcomas
A Phase II Study of Neoadjuvant Bevacizumab and Radiation Therapy for Resectable Soft Tissue Sarcomas
Status: Enrolling
Updated:  4/27/2010
Massachusetts General Hospital
mi
from
Boston, MA
Bevacizumab and Radiation Therapy for Sarcomas
A Phase II Study of Neoadjuvant Bevacizumab and Radiation Therapy for Resectable Soft Tissue Sarcomas
Status: Enrolling
Updated: 4/27/2010
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Status: Enrolling
Updated:  4/27/2010
Massachusetts General Hospital
mi
from
Boston, MA
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Status: Enrolling
Updated: 4/27/2010
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Status: Enrolling
Updated:  4/27/2010
Dana-Farber Cancer Institute/Brigham & Women's Hospital
mi
from
Boston, MA
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Status: Enrolling
Updated: 4/27/2010
Dana-Farber Cancer Institute/Brigham & Women's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Status: Enrolling
Updated:  4/27/2010
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Status: Enrolling
Updated: 4/27/2010
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Colorectal Cancer Screening Navigator Program for Low Income and Non-English Speaking Populations
Improving Colorectal Cancer Screening Rates by Lowering Barriers in Low Income and Non-English Speaking Populations: The Chelsea Colorectal Cancer Screening Project
Status: Enrolling
Updated:  4/30/2010
MGH Chelsea Health Center
mi
from
Chelsea, MA
Colorectal Cancer Screening Navigator Program for Low Income and Non-English Speaking Populations
Improving Colorectal Cancer Screening Rates by Lowering Barriers in Low Income and Non-English Speaking Populations: The Chelsea Colorectal Cancer Screening Project
Status: Enrolling
Updated: 4/30/2010
MGH Chelsea Health Center
mi
from
Chelsea, MA
Click here to add this to my saved trials
Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma
A Pilot Study of Perioperative Panitumumab in Combination With Epirubicin, Oxaliplatin and Xeloda in Patients With Resectable Gastroesophageal Adenocarcinoma
Status: Enrolling
Updated:  5/3/2010
Massachusetts General Hospital
mi
from
Boston, MA
Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma
A Pilot Study of Perioperative Panitumumab in Combination With Epirubicin, Oxaliplatin and Xeloda in Patients With Resectable Gastroesophageal Adenocarcinoma
Status: Enrolling
Updated: 5/3/2010
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma
A Pilot Study of Perioperative Panitumumab in Combination With Epirubicin, Oxaliplatin and Xeloda in Patients With Resectable Gastroesophageal Adenocarcinoma
Status: Enrolling
Updated:  5/3/2010
DFCI
mi
from
Boston, MA
Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma
A Pilot Study of Perioperative Panitumumab in Combination With Epirubicin, Oxaliplatin and Xeloda in Patients With Resectable Gastroesophageal Adenocarcinoma
Status: Enrolling
Updated: 5/3/2010
DFCI
mi
from
Boston, MA
Click here to add this to my saved trials
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
A Single Arm Phase II Trial of Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Status: Enrolling
Updated:  5/3/2010
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
A Single Arm Phase II Trial of Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Status: Enrolling
Updated: 5/3/2010
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
A Single Arm Phase II Trial of Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Status: Enrolling
Updated:  5/3/2010
Dana-Farber Cancer Institute
mi
from
Boston, MA
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
A Single Arm Phase II Trial of Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Status: Enrolling
Updated: 5/3/2010
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
A Single Arm Phase II Trial of Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Status: Enrolling
Updated:  5/3/2010
Massachusetts General Hospital
mi
from
Boston, MA
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
A Single Arm Phase II Trial of Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Status: Enrolling
Updated: 5/3/2010
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status: Enrolling
Updated:  5/11/2010
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status: Enrolling
Updated: 5/11/2010
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status: Enrolling
Updated:  5/11/2010
Dana-Farber Cancer Institute
mi
from
Boston, MA
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status: Enrolling
Updated: 5/11/2010
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status: Enrolling
Updated:  5/11/2010
Department of Radiation oncology, Memorial Sloan Kettering Cancer Center
mi
from
New York city, NY
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status: Enrolling
Updated: 5/11/2010
Department of Radiation oncology, Memorial Sloan Kettering Cancer Center
mi
from
New York city, NY
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status: Enrolling
Updated:  5/11/2010
UPMC Shadyside Radiation Oncology
mi
from
Pittsburgh, PA
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status: Enrolling
Updated: 5/11/2010
UPMC Shadyside Radiation Oncology
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
A Phase 1 Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma, for Which No Standard Therapy Is Available
Status: Enrolling
Updated:  5/13/2010
TGen Clinical Research Services at Scottsdale Healthcare
mi
from
Scottsdale, AZ
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
A Phase 1 Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma, for Which No Standard Therapy Is Available
Status: Enrolling
Updated: 5/13/2010
TGen Clinical Research Services at Scottsdale Healthcare
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
A Phase 1 Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma, for Which No Standard Therapy Is Available
Status: Enrolling
Updated:  5/13/2010
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
A Phase 1 Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma, for Which No Standard Therapy Is Available
Status: Enrolling
Updated: 5/13/2010
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions
Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions
Status: Enrolling
Updated:  5/18/2010
Emory University
mi
from
Atlanta, GA
Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions
Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions
Status: Enrolling
Updated: 5/18/2010
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
A Randomized, Placebo-controlled, Pre-surgical Study of the Effects of Pomegranate Pills in Men With Prostate Cancer Prior to Radical Prostatectomy
Status: Enrolling
Updated:  5/24/2010
UCLA
mi
from
Los Angeles, CA
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
A Randomized, Placebo-controlled, Pre-surgical Study of the Effects of Pomegranate Pills in Men With Prostate Cancer Prior to Radical Prostatectomy
Status: Enrolling
Updated: 5/24/2010
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
A Randomized, Placebo-controlled, Pre-surgical Study of the Effects of Pomegranate Pills in Men With Prostate Cancer Prior to Radical Prostatectomy
Status: Enrolling
Updated:  5/24/2010
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
A Randomized, Placebo-controlled, Pre-surgical Study of the Effects of Pomegranate Pills in Men With Prostate Cancer Prior to Radical Prostatectomy
Status: Enrolling
Updated: 5/24/2010
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
A Randomized, Placebo-controlled, Pre-surgical Study of the Effects of Pomegranate Pills in Men With Prostate Cancer Prior to Radical Prostatectomy
Status: Enrolling
Updated:  5/24/2010
Duke Univ Med Ctr
mi
from
Durham, NC
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
A Randomized, Placebo-controlled, Pre-surgical Study of the Effects of Pomegranate Pills in Men With Prostate Cancer Prior to Radical Prostatectomy
Status: Enrolling
Updated: 5/24/2010
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including Central Nervous System Tumors
A Phase I Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including CNS Tumors
Status: Enrolling
Updated:  6/1/2010
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including Central Nervous System Tumors
A Phase I Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including CNS Tumors
Status: Enrolling
Updated: 6/1/2010
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including Central Nervous System Tumors
A Phase I Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including CNS Tumors
Status: Enrolling
Updated:  6/1/2010
SSM Cardinal Glennon Children's Medical Center
mi
from
St. Louis, MO
Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including Central Nervous System Tumors
A Phase I Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including CNS Tumors
Status: Enrolling
Updated: 6/1/2010
SSM Cardinal Glennon Children's Medical Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including Central Nervous System Tumors
A Phase I Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including CNS Tumors
Status: Enrolling
Updated:  6/1/2010
Fletcher Allen Health Care
mi
from
Burlington, VT
Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including Central Nervous System Tumors
A Phase I Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including CNS Tumors
Status: Enrolling
Updated: 6/1/2010
Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer
Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer
Status: Enrolling
Updated:  6/1/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer
Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer
Status: Enrolling
Updated: 6/1/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Evaluating an Internet-based Intervention for Insomnia in Breast Cancer Survivors
Evaluating an Internet-based Intervention for Insomnia in Breast Cancer Survivors
Status: Enrolling
Updated:  6/10/2010
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Evaluating an Internet-based Intervention for Insomnia in Breast Cancer Survivors
Evaluating an Internet-based Intervention for Insomnia in Breast Cancer Survivors
Status: Enrolling
Updated: 6/10/2010
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
Investigating the Feasibility of Using Real-time Cine-MRI for Treating Moving and Deforming Tumors
Status: Enrolling
Updated:  6/24/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
Investigating the Feasibility of Using Real-time Cine-MRI for Treating Moving and Deforming Tumors
Status: Enrolling
Updated: 6/24/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials